Part 2 of our MNVC Recap Series on the MedTech Jam Session with Chris & Mike D! We pick up the conversation by finishing our recap of the Investor Roundtable panel and then share what CEO’s and Founders are thinking with their Go To Market approach and channel strategy. Hint: Capital efficiency is king! You can listen to MedTech Jam Session on Apple Podcasts, Spotify, and now, YouTube. Congratulations to all of the presenting companies and special thanks to Gary Stevenson and Healthpoint Capital for hosting this outstanding event.

The 2025 MNVC was an epic, sold out gathering of founders, builders, investors, and drivers of the orthopedic startup community. On this week’s MedTech Jam Session with Chris & Mike D, we have the two moderators that were in the ‘Room Where it Happened’ – Chris Lyons and Mike Sherman. In part 1, we discuss highlights from the panel, ‘Financing and M&A Environment for Private Companies’ by Charles Hamilton, and Key thoughts from the ‘Investor Roundtable’ panel featuring Gary Stevenson, Michael Collins, Chance Leonard, Nicholas Pachuda, and Jeffrey O’Donnell. Join us wherever you listen to podcasts and stay tuned for Part 2 releasing next week. Congratulations to all of the presenting companies for bringing a great conference to light! Powered by ConveyMed

Why do patients sometimes struggle to regain motion following a technically perfect tendon repair surgery? Adhesions from tissue tethering can keep patients from returning to normal activities. Meet B3 GEL™ from TYBR Health: A flowable, bioresorbable ECM gel that prevents restrictive scar tissue while supporting optimal healing. Chris Wright jams with Chris and I as he shares the origin story of the technology and the company, as well as their journey to achieving 510K approval. Listen to another great story of an entrepreneur who made a bold move to pivot into orthopedics after listening to customers. A lesson for us all! Check it out wherever you get your podcasts!

To learn more about TYBR Health, go to their LinkedIn page

Is there a ‘Missing Middle’ in tendon care? Many partial-tear patients find themselves in a treatment gap where PT or needle procedures fail, but they are not yet candidates for surgery. That’s where Trace Orthopedics is creating the future of tendon repair. Dr. Bill Morrison and CEO Adam Greenspan jam with Chris and Mike D. as they share their journey to launch the first device for tendon reattachment without surgery.

• Pivotal animal study complete

• Contract manufacturing established

• FDA path defined

• Targeting a limited market release in Q4 2026.

We love it when physicians invent the very challenges they face every day. To learn more about Trace Orthopedics, go to their ⁠⁠LinkedIn page.

⁠⁠ Another great jam session! Jam with us wherever you get your podcasts! 

Apple

Spotify 

A surgeon-led rethink of patella fractures launches Endeavor Orthopaedics. A failure rate of up to 40% in patella fractures was not acceptable to Dr. Brent Norris. “I had an epiphany in October of 2011. After a couple of challenging patella fracture cases, I realized, I was only addressing part of the extensor mechanism injury. By only treating the bony element of the injury with cannulated screws and orthopedic wire, we were not fully addressing the soft tissue component of the injury or more importantly the forces of the extensor mechanism.” In this week’s MedTech Jam Session with Chris & Mike D, check out the rest of the story from Dr. Norris and Endeavor CEO Greg Parranto as they discuss how they are solving, not just patella fractures, but how their platform will soon expand to treat other challenging avulsion injuries. Another great story of a surgeon with the courage to build next-generation solutions to benefit patient care.

Jam with us wherever you get your podcasts:  

Apple

Spotify 

Click here to learn more about Endeavor Orthopaedics, or go to: https://www.endeavorortho.com/

Powered by @conveymed

Building the future of Ortho for over 20+ years at the annual MNVC. Gary Stevenson shares the story behind launching the Musculoskeletal New Ventures Conference (MNVC) over 20 years ago in Memphis—a platform designed to bring together surgeon-entrepreneurs, MedTech investors, and startups in the ortho space. Here’s what we learned from Gary:

1. With orthopedic giants such as @Stryker, @SNN and @Medtronic Spine, Memphis became the perfect ecosystem for orthopedic innovation. MNVC helped fuel that by connecting capital with clinical insight

2. In an increasingly digital world, Gary emphasizes the enduring value of face-to-face deal-making, clinical validation, and peer exchange that MNVC enables—especially for early-stage startups needing visibility and feedback.

3. The conference has become a launchpad for surgeon-led startups, offering a rare stage where real-world clinical problems meet venture capital, and great ideas are accelerated. To learn more about the MNVC Conference visit MNVC.org

Tune into MedTech Jam Session wherever you get your podcasts!

Apple  

Spotify 

Will ‘Scopes as a Subscription’ be the new model for arthroscopy? Bryan Lord and Pristine Surgical sure make a compelling case as they announce their full US market release of Summit – a first of its kind, 4K single-use surgical arthroscope. Here’s what we learned from Bryan:

1. Pristine Surgical has reinvented endoscopy by introducing a single-use, high-definition endoscopy platform that turns capital equipment into a scalable SaaS-like business. Genius!

2. Every system is paired with a cloud-based software platform, giving surgeons tools for case recording, automated checklists, and data capture. Transforming the OR into a digitally connected environment is a gamechanger!

3. Bryan shares his transition from investor to operator, drawing on his background in private equity and venture investing to grow Pristine with capital efficiency and execution discipline.

Thanks to the team at Pristine for letting us jam Live from AOSSM. Listen to the full episode wherever you get your podcasts, Powered by ConveyMED on:

Apple  

Spotify 

Will a Two-Portal approach be the catalyst for widespread adoption of endoscopic spine? Andy Choi and the team at Amplify Surgical have cracked the code and are proving that their dualPortal solution can deliver enhanced visualization and greater flexibility for spine surgeons performing lumbar fusion cases through a minimally invasive approach. Check out our recent conversation with Andy as he shares his journey from Stryker spine to a startup founder, his disciplined approach to company scaling, and how their training program is leading to rapid growth. Chris Lyons and I had a blast jamming with Andy on this episode of the MedTech Jam session. Jam with us wherever you get your podcasts! 

Apple

Spotify

To learn more about Amplify Surgical visit AmplifySurgical.com

Imagine being able to detect compartment syndrome before symptoms appear. In our latest MedTech Jam Session, Chris and I speak with CEO Charles Allan of MY01 as he explains how their microsensor and continuous monitoring platform is helping trauma teams intervene earlier, avoid unnecessary fasciotomies, and improve outcomes for compartment syndrome. Here’s what we learned from Charlie:

1. MY01 has cracked the code by integrating their device into trauma clinical pathways. A smart commercial strategy!

2. With over 2,500 cases performed and a published study showing an average net savings of $2,800 per patient, MY01 not only improves patient outcomes but reduces costly fasciotomies and extended hospital stays. Great for the VAC process!

3. Founder Charles Allan shares how a family legacy in surgery and entrepreneurship, combined with a collaboration with orthopedic trauma surgeon Dr. Ed Harvey, led to the development of MY01’s groundbreaking technology Check out my01.io to learn more.

Tune into MedTech Jam Session wherever you get your podcasts:

Apple  

Spotify

Meet Scott DeFelice and the team at OPM as they usher in the next big material innovation in orthopedics. In this MedTech Jam Session, Scott explains how PEKK offers true bone-like mechanics, osseointegration, radiolucency, and intrinsic antibacterial/antiviral performance. Here’s what we learned from Scott:

1. Tackling the Toughest Cases First - From oncology to arthrodesis, OPM’s PEKK implants are solving high-risk, high-complication surgeries.

2. An Infection-Resistant Material - With a 1.5% infection rate vs. 20% for traditional materials, clinicians are rapidly adopting the tech for the most challenging cases.

3. Patient-Matched Precision at Scale - With over 4,500 personalized craniofacial implants delivered and growing into extremity, trauma, and oncology applications, OPM brings perfect-fit, 3D-printed implants to complex cases

Tune into MedTech Jam Session to see where high-performance polymers meet better patient outcomes – wherever you get your podcasts! To learn more about Oxford Performance Materials, visit: OxfordPM.com

Listen to this episode wherever you get your podcasts!

Apple

Spotify